Context

Many randomised double-blind short-term growth studies have been performed in the last two decades showing that inhaled glucocorticoids are associated with a significant risk of dose-related growth suppression in prepubertal children.1–⇓3 Despite having been on the market since the early 1980s for use in children, the potential of inhaled glucocorticoids for suppression of final height, however, has not yet been clarified. This study aimed to answer the question: what happens to adult height in children who present a growth deficit caused by few years’ treatment with inhaled glucocorticoids in childhood?